Back to Search Start Over

Effects of iso-α-acids, the hop-derived bitter components in beer, on the MRI-based Brain Healthcare Quotient in healthy middle-aged to older adults.

Authors :
Kita M
Yoshida S
Kondo K
Yamakawa Y
Ano Y
Source :
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2019 Dec; Vol. 39 (4), pp. 273-278. Date of Electronic Publication: 2019 Oct 06.
Publication Year :
2019

Abstract

Aim: Neurological disorders are a major public health issue worldwide and are often associated with structural changes in the brain. We have previously demonstrated that iso-α-acids (IAAs), the hop-derived bitter components in beer, improve memory impairment in aged and Alzheimer's disease mouse models. In this study, we evaluated the effects of IAA intake on the brain structure in healthy middle-aged to older adults. This study was conducted under the Impulsing Paradigm Change through Disruptive Technologies Program (ImPACT) study launched by the Cabinet office of Japan.<br />Method: This study employed an open-labeled, single-arm, before and after design. Healthy middle-aged to older adults consumed a beverage containing IAAs (3 mg/190 mL) for 4 weeks.Recently developed magnetic resonance imaging-based brain health indicators were used to evaluate the following brain conditions: the Brain Healthcare Quotient (BHQ) based on gray matter volume (GM-BHQ) and white matter fractional anisotropy (FA-BHQ).<br />Results: In total, 25 subjects were recruited, and GM-BHQ and FA-BHQ were measured before and after intervention. In all subjects, no significant differences in GM-BHQ and FA-BHQ were observed. In subjects aged ≥ 60 years (mean 54.5; standard deviation 3.9) (n = 8), GM-BHQ was significantly increased 4 weeks after intervention compared with that before intervention.<br />Conclusion: Intake of beverages containing IAAs might affect brain aging, particularly in healthy older adults, which may prevent the development of neurological disorders. Future studies employing more robust designs can elucidate the effects of IAAs on GM-BHQ and cognitive functions.<br /> (© 2019. Research Laboratories for Health Science & Food Technologies, Kirin Company Limited. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.)

Details

Language :
English
ISSN :
2574-173X
Volume :
39
Issue :
4
Database :
MEDLINE
Journal :
Neuropsychopharmacology reports
Publication Type :
Academic Journal
Accession number :
31587526
Full Text :
https://doi.org/10.1002/npr2.12077